Sign In

Login

Password

Forgot Password ? Sign Up

Kannabidiol (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kannabidiol" in Polish language version.

refsWebsite
Global rank Polish rank
19doi.org
2nd place
6th place
18nih.gov
4th place
7th place
2sigmaaldrich.com
924th place
75th place
1unodc.org
2,494th place
2,839th place
1fda.gov
447th place
1,118th place

doi.org

dx.doi.org

  • Otto-Erich Schultz, Gert Haffner, Zur Kenntnis eines sedativen Wirkstoffes aus dem deutschen Faserhanf (Cannabis sativa), „Archiv der Pharmazie”, 291 (8), 1958, s. 391–403, DOI: 10.1002/ardp.19582910804.
  • Zerrin Atakan, Cannabis, a complex plant: different compounds and different effects on individuals, „Therapeutic Advances in Psychopharmacology”, 2 (6), 2012, s. 241–254, DOI: 10.1177/2045125312457586, PMID: 23983983, PMCID: PMC3736954.
  • Scott E. Hadland, John R. Knight, Sion K. Harris, Medical Marijuana: Review of the Science and Implications for Developmental Behavioral Pediatric Practice, „Journal of Developmental and Behavioral Pediatrics”, 36 (2), 2015, s. 115–123, DOI: 10.1097/DBP.0000000000000129, PMID: 25650954, PMCID: PMC4318349.
  • Christopher T. Campbell, Marjorie Shaw Phillips, Kalen Manasco, Cannabinoids in Pediatrics, „The Journal of Pediatric Pharmacology and Therapeutics”, 22 (3), 2017, s. 176–185, DOI: 10.5863/1551-6776-22.3.176, PMID: 28638299, PMCID: PMC5473390.
  • David Gloss, Barbara Vickrey, Cannabinoids for epilepsy (Review), „Cochrane Database of Systematic Reviews”, 5 (3), 2014, DOI: 10.1002/14651858.CD009270.pub3, PMID: 24595491.
  • Barbara S. Koppel i inni, Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders, „Neurology”, 82 (17), 2014, s. 1556–1563, DOI: 10.1212/WNL.0000000000000363, PMID: 24778283, PMCID: PMC4011465.
  • Maria Roberta Cilio, Elizabeth A. Thiele, Orrin Devinsky, The case for assessing cannabidiol in epilepsy, „Epilepsia”, 55 (6), 2014, s. 787–790, DOI: 10.1111/epi.12635, PMID: 24854434.
  • Craig A. Press, Kelly G. Knupp, Kevin E. Chapman, Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy, „Epilepsy & Behavior”, 45, 2015, s. 49–52, DOI: 10.1016/j.yebeh.2015.02.043, PMID: 25845492.
  • Celia J.A. Morgan, H. Valerie Curran, Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis, „The British Journal of Psychiatry”, 192 (4), 2008, s. 306–307, DOI: 10.1192/bjp.bp.107.046649, PMID: 18378995.
  • Alline Cristina Campos, Francisco Silveira Guimarães, Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats, „Psychopharmacology”, 199 (2), 2008, s. 223–230, DOI: 10.1007/s00213-008-1168-x, PMID: 18446323.
  • Esther M. Blessing i inni, Cannabidiol as a Potential Treatment for Anxiety Disorders, „Neurotherapeutics”, 12 (4), 2015, s. 825–836, DOI: 10.1007/s13311-015-0387-1, PMID: 26341731, PMCID: PMC4604171.
  • Rudolf Moldzio i inni, Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures, „Phytomedicine: International Journal of Phytotherapy and Phytopharmacology”, 19 (8-9), 2012, s. 819–824, DOI: 10.1016/j.phymed.2012.04.002, PMID: 22571976.
  • M. Ruth Pazos i inni, Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT1A and CB2 receptors, „Neuropharmacology”, 71, 2013, s. 282–291, DOI: 10.1016/j.neuropharm.2013.03.027, PMID: 23587650.
  • Scott Shannon i inni, Cannabidiol in Anxiety and Sleep: A Large Case Series, „The Permanente Journal”, 23, 2019, DOI: 10.7812/TPP/18-041, PMID: 30624194, PMCID: PMC6326553.
  • Kimberly A. Babson, James Sottile, Danielle Morabito, Cannabis, Cannabinoids, and Sleep: a Review of the Literature, „Current Psychiatry Reports”, 19 (4), 2017, s. 23, DOI: 10.1007/s11920-017-0775-9, PMID: 28349316.
  • Angelo Vaccani i inni, Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism, „British Journal of Pharmacology”, 144 (8), 2005, s. 1032–1036, DOI: 10.1038/sj.bjp.0706134, PMID: 15700028, PMCID: PMC1576089.
  • P. Massi i inni, The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells, „Cellular and molecular life sciences: CMLS”, 63 (17), 2006, s. 2057–2066, DOI: 10.1007/s00018-006-6156-x, PMID: 16909207.
  • Ashutosh Shrivastava i inni, Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy, „Molecular Cancer Therapeutics”, 10 (7), 2011, s. 1161–1172, DOI: 10.1158/1535-7163.MCT-10-1100, PMID: 21566064.
  • Robert Ramer i inni, Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1, „Biochemical Pharmacology”, 79 (7), 2010, s. 955–966, DOI: 10.1016/j.bcp.2009.11.007, PMID: 19914218.

fda.gov

nih.gov

ncbi.nlm.nih.gov

  • Zerrin Atakan, Cannabis, a complex plant: different compounds and different effects on individuals, „Therapeutic Advances in Psychopharmacology”, 2 (6), 2012, s. 241–254, DOI: 10.1177/2045125312457586, PMID: 23983983, PMCID: PMC3736954.
  • Scott E. Hadland, John R. Knight, Sion K. Harris, Medical Marijuana: Review of the Science and Implications for Developmental Behavioral Pediatric Practice, „Journal of Developmental and Behavioral Pediatrics”, 36 (2), 2015, s. 115–123, DOI: 10.1097/DBP.0000000000000129, PMID: 25650954, PMCID: PMC4318349.
  • Christopher T. Campbell, Marjorie Shaw Phillips, Kalen Manasco, Cannabinoids in Pediatrics, „The Journal of Pediatric Pharmacology and Therapeutics”, 22 (3), 2017, s. 176–185, DOI: 10.5863/1551-6776-22.3.176, PMID: 28638299, PMCID: PMC5473390.
  • David Gloss, Barbara Vickrey, Cannabinoids for epilepsy (Review), „Cochrane Database of Systematic Reviews”, 5 (3), 2014, DOI: 10.1002/14651858.CD009270.pub3, PMID: 24595491.
  • Barbara S. Koppel i inni, Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders, „Neurology”, 82 (17), 2014, s. 1556–1563, DOI: 10.1212/WNL.0000000000000363, PMID: 24778283, PMCID: PMC4011465.
  • Maria Roberta Cilio, Elizabeth A. Thiele, Orrin Devinsky, The case for assessing cannabidiol in epilepsy, „Epilepsia”, 55 (6), 2014, s. 787–790, DOI: 10.1111/epi.12635, PMID: 24854434.
  • Craig A. Press, Kelly G. Knupp, Kevin E. Chapman, Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy, „Epilepsy & Behavior”, 45, 2015, s. 49–52, DOI: 10.1016/j.yebeh.2015.02.043, PMID: 25845492.
  • Celia J.A. Morgan, H. Valerie Curran, Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis, „The British Journal of Psychiatry”, 192 (4), 2008, s. 306–307, DOI: 10.1192/bjp.bp.107.046649, PMID: 18378995.
  • Alline Cristina Campos, Francisco Silveira Guimarães, Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats, „Psychopharmacology”, 199 (2), 2008, s. 223–230, DOI: 10.1007/s00213-008-1168-x, PMID: 18446323.
  • Esther M. Blessing i inni, Cannabidiol as a Potential Treatment for Anxiety Disorders, „Neurotherapeutics”, 12 (4), 2015, s. 825–836, DOI: 10.1007/s13311-015-0387-1, PMID: 26341731, PMCID: PMC4604171.
  • Rudolf Moldzio i inni, Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures, „Phytomedicine: International Journal of Phytotherapy and Phytopharmacology”, 19 (8-9), 2012, s. 819–824, DOI: 10.1016/j.phymed.2012.04.002, PMID: 22571976.
  • M. Ruth Pazos i inni, Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT1A and CB2 receptors, „Neuropharmacology”, 71, 2013, s. 282–291, DOI: 10.1016/j.neuropharm.2013.03.027, PMID: 23587650.
  • Scott Shannon i inni, Cannabidiol in Anxiety and Sleep: A Large Case Series, „The Permanente Journal”, 23, 2019, DOI: 10.7812/TPP/18-041, PMID: 30624194, PMCID: PMC6326553.
  • Kimberly A. Babson, James Sottile, Danielle Morabito, Cannabis, Cannabinoids, and Sleep: a Review of the Literature, „Current Psychiatry Reports”, 19 (4), 2017, s. 23, DOI: 10.1007/s11920-017-0775-9, PMID: 28349316.
  • Angelo Vaccani i inni, Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism, „British Journal of Pharmacology”, 144 (8), 2005, s. 1032–1036, DOI: 10.1038/sj.bjp.0706134, PMID: 15700028, PMCID: PMC1576089.
  • P. Massi i inni, The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells, „Cellular and molecular life sciences: CMLS”, 63 (17), 2006, s. 2057–2066, DOI: 10.1007/s00018-006-6156-x, PMID: 16909207.
  • Ashutosh Shrivastava i inni, Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy, „Molecular Cancer Therapeutics”, 10 (7), 2011, s. 1161–1172, DOI: 10.1158/1535-7163.MCT-10-1100, PMID: 21566064.
  • Robert Ramer i inni, Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1, „Biochemical Pharmacology”, 79 (7), 2010, s. 955–966, DOI: 10.1016/j.bcp.2009.11.007, PMID: 19914218.

sigmaaldrich.com

unodc.org